These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
699 related items for PubMed ID: 26205553
1. Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin. Bello S, Fandos S, Lasierra AB, Mincholé E, Panadero C, Simon AL, Gavin O, De Pablo F, Menendez R, Torres A. Respir Med; 2015 Sep; 109(9):1193-206. PubMed ID: 26205553 [Abstract] [Full Text] [Related]
2. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia. Courtais C, Kuster N, Dupuy AM, Folschveiller M, Jreige R, Bargnoux AS, Guiot J, Lefebvre S, Cristol JP, Sebbane M. Am J Emerg Med; 2013 Jan; 31(1):215-21. PubMed ID: 23000327 [Abstract] [Full Text] [Related]
3. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ. Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T, German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group. Am J Respir Crit Care Med; 2010 Dec 01; 182(11):1426-34. PubMed ID: 20639437 [Abstract] [Full Text] [Related]
4. Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia. Gordo-Remartínez S, Calderón-Moreno M, Fernández-Herranz J, Castuera-Gil A, Gallego-Alonso-Colmenares M, Puertas-López C, Nuevo-González JA, Sánchez-Sendín D, García-Gámiz M, Sevillano-Fernández JA, Álvarez-Sala LA, Andueza-Lillo JA, de Miguel-Yanes JM. PLoS One; 2015 Dec 01; 10(6):e0125212. PubMed ID: 26030588 [Abstract] [Full Text] [Related]
11. Elevated Red Blood Cell Distribution Width Combined White Blood Cell in Peripheral Blood Routine Have a Better Sensitivity than CURB-65 Scores in Predicting ICU Admission and Mortality in Adult Community-Acquired Pneumonia Patients. Ge YL, Liu CH, Rana MA, Zhu XY, Wang N, Xu J, Su CS, Li HL, Li ZZ, Hassan RA, Li HL, Zhang HF, Zhang X, Yu HL, Zhang JB, Fu AS, Wang HY. Clin Lab; 2019 Mar 01; 65(3):. PubMed ID: 30868855 [Abstract] [Full Text] [Related]
12. [Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department]. Julián-Jiménez A, Timón Zapata J, Laserna Mendieta EJ, Sicilia-Bravo I, Palomo-de Los Reyes MJ, Cabezas-Martínez A, Laín-Terés N, Estebaran-Martín J, Lozano-Ancín A, Cuena-Boy R. Enferm Infecc Microbiol Clin; 2014 Apr 01; 32(4):225-35. PubMed ID: 24182623 [Abstract] [Full Text] [Related]
14. Changes in Red Cell Distribution Width During Hospitalization for Community-Acquired Pneumonia: Clinical Characteristics and Prognostic Significance. Gorelik O, Izhakian S, Barchel D, Almoznino-Sarafian D, Tzur I, Swarka M, Beberashvili I, Feldman L, Cohen N, Shteinshnaider M. Lung; 2016 Dec 01; 194(6):985-995. PubMed ID: 27650510 [Abstract] [Full Text] [Related]
15. Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB. Legramante JM, Mastropasqua M, Susi B, Porzio O, Mazza M, Miranda Agrippino G, D Agostini C, Brandi A, Giovagnoli G, Di Lecce VN, Bernardini S, Minieri M. PLoS One; 2017 Dec 01; 12(11):e0187702. PubMed ID: 29161297 [Abstract] [Full Text] [Related]
18. Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis. Liu D, Xie L, Zhao H, Liu X, Cao J. BMC Infect Dis; 2016 May 26; 16():232. PubMed ID: 27230573 [Abstract] [Full Text] [Related]